Table 4 Cell cycle alteration after bortezomib treatment
Cell line | Group | Percentage of cells in different cell cycle phases (%) | ||
|---|---|---|---|---|
Phase G1 | Phase S | Phase G2 | ||
U251 | Control | 43.87 ± 2.77 | 38.12 ± 3.50 | 18.01 ± 2.23 |
10 nmol/L | 54.44 ± 6.32 | 33.42 ± 3.22 | 12.15 ± 1.22 | |
20 nmol/L | 70.83 ± 7.54 | 22.42 ± 2.52 | 6.74 ± 2.10 | |
U87 | Control | 45.97 ± 2.99 | 37.06 ± 2.52 | 16.97 ± 1.88 |
10 nmol/L | 53.1 ± 64.3 | 32.41 ± 2.21 | 14.43 ± 1.90 | |
20 nmol/L | 76.35 ± 6.54 | 14.89 ± 1.50 | 8.76 ± 2.22 | |